Tissue-specific multi-omics analysis of atrial fibrillation.
Ines AssumJulia KrauseMarkus O ScheinhardtChristian MüllerElke HammerChristin S BörschelLinus VölkerLenard ConradiBastiaan GeelhoedTanja ZellerRenate B SchnabelMatthias HeinigPublished in: Nature communications (2022)
Genome-wide association studies (GWAS) for atrial fibrillation (AF) have uncovered numerous disease-associated variants. Their underlying molecular mechanisms, especially consequences for mRNA and protein expression remain largely elusive. Thus, refined multi-omics approaches are needed for deciphering the underlying molecular networks. Here, we integrate genomics, transcriptomics, and proteomics of human atrial tissue in a cross-sectional study to identify widespread effects of genetic variants on both transcript (cis-eQTL) and protein (cis-pQTL) abundance. We further establish a novel targeted trans-QTL approach based on polygenic risk scores to determine candidates for AF core genes. Using this approach, we identify two trans-eQTLs and five trans-pQTLs for AF GWAS hits, and elucidate the role of the transcription factor NKX2-5 as a link between the GWAS SNP rs9481842 and AF. Altogether, we present an integrative multi-omics method to uncover trans-acting networks in small datasets and provide a rich resource of atrial tissue-specific regulatory variants for transcript and protein levels for cardiovascular disease gene prioritization.
Keyphrases
- atrial fibrillation
- single cell
- rna seq
- catheter ablation
- left atrial
- transcription factor
- oral anticoagulants
- copy number
- genome wide
- cardiovascular disease
- left atrial appendage
- direct oral anticoagulants
- genome wide association
- heart failure
- genome wide identification
- percutaneous coronary intervention
- endothelial cells
- protein protein
- binding protein
- mass spectrometry
- amino acid
- high density
- small molecule
- risk factors
- microbial community
- dna binding
- coronary artery disease
- venous thromboembolism
- mitral valve
- single molecule
- genetic diversity
- case control